Docetaxel response in BRCA1,p53-deficient mammary tumor cells is affected by Huntingtin and BAP1

Proceedings of the National Academy of Sciences, Volume 121, Issue 52, December 2024.
SignificanceChemotherapy with taxanes, essential in treating various cancers, including TNBC, often faces challenges due to unpredictable patient responses and the emergence of secondary resistance. This unpredictability is exacerbated by intra- and …
Source : National Academy of Sciences